| Lastest Insider Transactions Of KalVista Pharmaceuticals, Inc. ( KALV ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2025-03-06 | Sell | 6,669 | 11.97 | 79,828 | 2025-03-10 18:43:21 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2025-03-06 | Option Exercise | 15,625 | 0.00 | 0 | 2025-03-10 18:43:21 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2025-02-22 | Sell | 2,394 | 10.02 | 23,988 | 2025-02-25 20:37:22 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2025-02-22 | Option Exercise | 5,000 | 0.00 | 0 | 2025-02-25 20:37:22 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2025-02-21 | Sell | 1,918 | 10.02 | 19,218 | 2025-02-25 20:36:14 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2025-02-21 | Option Exercise | 3,125 | 0.00 | 0 | 2025-02-25 20:36:14 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2025-02-17 | Sell | 2,601 | 9.82 | 25,553 | 2025-02-19 20:47:31 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2025-02-17 | Option Exercise | 4,204 | 0.00 | 0 | 2025-02-19 20:47:31 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2025-02-17 | Sell | 3,125 | 9.82 | 30,701 | 2025-02-19 20:46:58 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2025-02-17 | Option Exercise | 6,447 | 0.00 | 0 | 2025-02-19 20:46:58 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2025-02-17 | Sell | 5,104 | 9.82 | 50,143 | 2025-02-19 20:46:26 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2025-02-17 | Option Exercise | 9,363 | 0.00 | 0 | 2025-02-19 20:46:26 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2025-02-12 | Buy | 161,700 | 9.27 | 1,498,661 | 2025-02-14 19:45:15 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2025-02-07 | Buy | 104,489 | 9.26 | 967,145 | 2025-02-11 19:51:08 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2025-02-07 | Buy | 104,489 | 9.26 | 967,145 | 2025-02-11 19:51:08 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2025-02-07 | Buy | 104,489 | 9.26 | 967,145 | 2025-02-11 19:51:08 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2025-01-30 | Buy | 70,023 | 8.88 | 621,628 | 2025-02-03 19:42:00 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2024-12-06 | Sell | 7,627 | 9.75 | 74,363 | 2024-12-09 21:08:08 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2024-12-06 | Option Exercise | 15,625 | 0.00 | 0 | 2024-12-09 21:08:08 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2024-11-22 | Sell | 2,187 | 9.87 | 21,586 | 2024-11-27 20:45:34 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2024-11-22 | Option Exercise | 5,000 | 0.00 | 0 | 2024-11-27 20:45:34 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2024-11-22 | Sell | 1,963 | 9.87 | 19,378 | 2024-11-27 20:43:46 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2024-11-22 | Option Exercise | 3,125 | 0.00 | 0 | 2024-11-27 20:43:46 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2024-11-17 | Sell | 14,400 | 9.26 | 133,294 | 2024-11-19 19:19:24 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2024-11-17 | Option Exercise | 30,198 | 0.00 | 0 | 2024-11-19 19:19:24 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2024-11-17 | Sell | 7,192 | 9.26 | 66,573 | 2024-11-19 19:18:39 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2024-11-17 | Option Exercise | 11,496 | 0.00 | 0 | 2024-11-19 19:18:39 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2024-11-17 | Sell | 8,077 | 9.26 | 74,766 | 2024-11-19 19:18:06 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2024-11-17 | Option Exercise | 18,531 | 0.00 | 0 | 2024-11-19 19:18:06 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2024-08-17 | Sell | 7,973 | 12.01 | 95,782 | 2024-08-21 21:26:19 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2024-08-17 | Option Exercise | 18,528 | 0.00 | 0 | 2024-08-21 21:26:19 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2024-08-17 | Sell | 14,215 | 12.01 | 170,769 | 2024-08-21 21:25:42 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2024-08-17 | Option Exercise | 30,195 | 0.00 | 0 | 2024-08-21 21:25:42 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2024-08-17 | Sell | 7,102 | 12.01 | 85,318 | 2024-08-21 21:25:05 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2024-08-17 | Option Exercise | 11,495 | 0.00 | 0 | 2024-08-21 21:25:05 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2024-06-06 | Sell | 7,465 | 11.53 | 86,068 | 2024-06-10 18:42:49 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2024-06-06 | Option Exercise | 15,625 | 0.00 | 0 | 2024-06-10 18:42:49 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | 2024-05-17 | Sell | 8,088 | 11.76 | 95,151 | 2024-05-21 17:59:02 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | 2024-05-17 | Option Exercise | 18,789 | 0.00 | 0 | 2024-05-21 17:59:02 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2024-05-17 | Sell | 13,175 | 11.76 | 154,997 | 2024-05-21 17:58:13 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2024-05-17 | Option Exercise | 30,614 | 0.00 | 0 | 2024-05-21 17:58:13 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2024-05-17 | Sell | 21,959 | 11.76 | 258,337 | 2024-05-21 17:57:09 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 2024-05-17 | Option Exercise | 51,031 | 0.00 | 0 | 2024-05-21 17:57:09 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2024-05-17 | Sell | 11,610 | 11.76 | 136,586 | 2024-05-21 17:55:36 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2024-05-17 | Option Exercise | 18,789 | 0.00 | 0 | 2024-05-21 17:55:36 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | 2024-02-17 | Sell | 28,288 | 14.07 | 397,929 | 2024-02-21 21:51:28 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | 2024-02-17 | Option Exercise | 18,788 | 0.00 | 0 | 2024-02-21 21:51:28 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2024-02-17 | Sell | 12,053 | 14.11 | 170,124 | 2024-02-21 21:48:58 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2024-02-17 | Option Exercise | 18,788 | 0.00 | 0 | 2024-02-21 21:48:58 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CFO, CBO | 2024-02-17 | Sell | 22,802 | 14.11 | 321,846 | 2024-02-21 21:46:54 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CFO, CBO | 2024-02-17 | Option Exercise | 51,029 | 0.00 | 0 | 2024-02-21 21:46:54 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2024-02-17 | Sell | 14,295 | 14.12 | 201,774 | 2024-02-21 21:44:15 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | 2024-02-17 | Option Exercise | 30,613 | 0.00 | 0 | 2024-02-21 21:44:15 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2024-02-17 | Sell | 24,888 | 14.11 | 351,289 | 2024-02-21 21:41:48 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2024-02-17 | Option Exercise | 54,415 | 0.00 | 0 | 2024-02-21 21:41:48 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CFO, CBO | 2024-02-14 | Sell | 40,855 | 15.01 | 613,205 | 2024-02-16 16:21:06 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2024-02-14 | Sell | 58,356 | 15.01 | 875,883 | 2024-02-16 16:20:08 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | 2024-02-14 | Sell | 28,171 | 15.01 | 422,827 | 2024-02-16 16:19:17 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | 2024-02-14 | Sell | 39,886 | 15.01 | 598,661 | 2024-02-16 16:18:15 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2024-02-06 | Buy | 86,048 | 14.62 | 1,257,829 | 2024-02-08 20:11:37 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2024-02-01 | Sell | 10,000 | 16.22 | 162,198 | 2024-02-05 17:55:05 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2024-01-30 | Buy | 88,099 | 14.47 | 1,274,793 | 2024-02-01 16:38:43 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2024-01-25 | Buy | 91,804 | 14.05 | 1,289,802 | 2024-01-29 19:07:16 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2024-01-22 | Buy | 99,129 | 12.53 | 1,241,685 | 2024-01-24 20:24:01 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2024-01-17 | Buy | 143,605 | 12.55 | 1,801,602 | 2024-01-19 18:02:25 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2024-01-11 | Buy | 26,246 | 12.72 | 333,779 | 2024-01-16 19:04:01 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2024-01-11 | Sell | 22,679 | 13.03 | 295,514 | 2024-01-12 16:26:35 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2024-01-08 | Buy | 137,700 | 12.54 | 1,726,457 | 2024-01-10 20:57:21 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2024-01-08 | Sell | 17,321 | 13.01 | 225,300 | 2024-01-10 18:05:48 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2024-01-03 | Buy | 59,369 | 12.14 | 720,543 | 2024-01-05 16:13:51 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 2023-12-27 | Buy | 519,017 | 12.46 | 6,465,650 | 2023-12-29 18:44:02 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2023-12-27 | Sell | 30,000 | 12.02 | 360,453 | 2023-12-28 16:28:48 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | 2023-11-17 | Sell | 7,985 | 8.23 | 65,711 | 2023-11-21 16:34:24 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | 2023-11-17 | Option Exercise | 18,530 | 0.00 | 0 | 2023-11-21 16:34:24 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2023-11-17 | Sell | 4,958 | 8.23 | 40,801 | 2023-11-21 16:33:21 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2023-11-17 | Option Exercise | 11,497 | 0.00 | 0 | 2023-11-21 16:33:21 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2023-11-17 | Sell | 7,113 | 8.23 | 58,535 | 2023-11-21 16:32:21 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2023-11-17 | Option Exercise | 11,497 | 0.00 | 0 | 2023-11-21 16:32:21 |
| KALV | KalVista Pharmaceuticals, Inc. | Cha Albert | Directior | 2023-09-11 | Sell | 18,000 | 10.50 | 189,050 | 2023-09-13 16:29:52 |
| KALV | KalVista Pharmaceuticals, Inc. | Cha Albert | Directior | 2023-09-11 | Option Exercise | 18,000 | 7.49 | 134,820 | 2023-09-13 16:29:52 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | 2023-08-17 | Sell | 8,020 | 10.73 | 86,045 | 2023-08-21 20:09:00 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | 2023-08-17 | Option Exercise | 18,529 | 0.00 | 0 | 2023-08-21 20:09:00 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2023-08-17 | Sell | 4,976 | 10.73 | 53,386 | 2023-08-21 20:07:52 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2023-08-17 | Option Exercise | 11,494 | 0.00 | 0 | 2023-08-21 20:07:52 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2023-08-17 | Sell | 7,142 | 10.73 | 76,624 | 2023-08-21 20:06:46 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2023-08-17 | Option Exercise | 11,494 | 0.00 | 0 | 2023-08-21 20:06:46 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2023-08-17 | Sell | 14,876 | 10.73 | 159,602 | 2023-08-21 20:05:04 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2023-08-17 | Option Exercise | 33,582 | 0.00 | 0 | 2023-08-21 20:05:04 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2023-01-11 | Sell | 2,604 | 10.14 | 26,416 | 2023-05-19 21:20:00 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2023-01-11 | Option Exercise | 4,205 | 0.00 | 0 | 2023-05-19 21:20:00 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2023-01-11 | Sell | 1,786 | 10.14 | 18,118 | 2023-05-19 21:18:18 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2023-01-11 | Option Exercise | 4,205 | 0.00 | 0 | 2023-05-19 21:18:18 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2023-01-11 | Sell | 5,627 | 10.14 | 57,083 | 2023-05-19 21:17:36 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2023-01-11 | Option Exercise | 12,750 | 0.00 | 0 | 2023-05-19 21:17:36 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | 2023-01-11 | Sell | 2,780 | 10.14 | 28,201 | 2023-05-19 21:16:57 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | 2023-01-11 | Option Exercise | 6,447 | 0.00 | 0 | 2023-05-19 21:16:57 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | 2023-02-17 | Sell | 3,412 | 7.66 | 26,136 | 2023-02-23 17:44:53 |
| KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | 2023-02-17 | Option Exercise | 6,446 | 0.00 | 0 | 2023-02-23 17:44:53 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2023-02-17 | Sell | 2,228 | 7.66 | 17,066 | 2023-02-23 17:44:05 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2023-02-17 | Option Exercise | 4,204 | 0.00 | 0 | 2023-02-23 17:44:05 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2023-02-17 | Sell | 2,228 | 7.66 | 17,066 | 2023-02-23 17:44:05 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2023-02-17 | Option Exercise | 4,204 | 0.00 | 0 | 2023-02-23 17:44:05 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2023-02-17 | Sell | 2,727 | 7.66 | 20,889 | 2023-02-23 17:42:44 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2023-02-17 | Option Exercise | 4,204 | 0.00 | 0 | 2023-02-23 17:42:44 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2023-02-17 | Sell | 6,700 | 7.66 | 51,322 | 2023-02-23 17:40:48 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2023-02-17 | Option Exercise | 12,749 | 0.00 | 0 | 2023-02-23 17:40:48 |
